drugset / Trial / NCT01770431

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy

NCT01770431 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of Huaier Granule for prevention of recurrence and metastasis of hepatocarcinoma after radical hepatectomy.

Timeline

Start
2011-08
Primary completion
2016-08
Completion
2016-08

Outcome

Met primary endpoint

registry analysis (superiority test); Huaier Granule Group vs Bank-control Group; p = 0.0001; chi-squared 14.7315; Cochran-Mantel-Haenszel NCT01770431 ↗

paper The difference in the RFS rate between Huaier and control groups was 62.39% and 49.05% (95% CI 6.74 to 19.94; p=0.0001); PMID 29802174 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Huaier Granule Traditional medicine (herbal / TCM) 20 g Oral